Company Laropharm Srl with Fiscal Code 14099517
recorded a turnover of 2024 of
32.654.927,
with a net profit of
1.320.920
and having an average number of employees of
420.
The company operates in the field of Fabricarea preparatelor farmaceutice having the NACE code 2120.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Laropharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
7.827.173
9.245.876
9.506.841
11.681.444
14.133.834
19.312.420
20.228.750
26.624.060
31.139.919
32.654.927
Total Income - EUR
7.917.109
9.506.596
9.721.605
11.826.475
14.304.457
19.930.074
20.577.434
27.292.017
31.761.828
33.191.917
Total Expenses - EUR
7.507.308
8.397.333
9.322.410
11.127.558
12.708.166
16.480.549
19.452.476
26.309.544
30.041.841
31.798.401
Gross Profit/Loss - EUR
409.800
1.109.263
399.196
698.917
1.596.291
3.449.525
1.124.958
982.474
1.719.987
1.393.515
Net Profit/Loss - EUR
354.454
1.002.350
286.133
623.149
1.383.532
3.001.788
1.019.588
852.961
1.483.157
1.320.920
Employees
192
220
236
247
254
301
321
349
384
420
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 5.5%, from 31.139.919 euro in the year 2023, to 32.654.927 euro in 2024.
The Net Profit decreased by -153.948 euro, from 1.483.157 euro in 2023, to 1.320.920 in the last year.
Check the financial reports for the company - Laropharm Srl
Financial Rating - LAROPHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Laropharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Laropharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Laropharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
15.329.414 euro in 2024 which includes Inventories of
7.179.903 euro, Receivables of
7.971.677 euro and cash availability of
177.833 euro.
The company's Equity was valued at
12.282.479 euro, while total Liabilities amounted to
17.511.132 euro.
Equity increased by 1.320.920 euro, from 11.023.164 euro in 2023, to 12.282.479 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Laropharm Srl